US Food and Drug Administration Shifts to AI-Enhanced Regulatory Review With Elsa 4.0 and HALO.
Where this comes from
- Record sourced from PubMed, PMID 42213502.
- Also identified by DOI 10.2196/101884.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The US Food and Drug Administration recently announced the launch of Elsa 4.0 and Harmonized AI and Lifecycle Operations for Data (HALO)-an upgrade to its artificial intelligence platform. In this News and Perspectives article, JMIR Correspondent Tejas S Athni reports on the evolution of the Elsa model and potential benefits and challenges.
Medical subject headings
- United States Food and Drug Administration
- Artificial Intelligence